Find your next paid study

The University of Texas Medical Branch, GalvestonNCT06681207

Actual pay is set by the research site.

Novel Mechanisms and Therapeutic Approaches for Nasal Obstruction and Olfactory Losses

About 13% of US adults, some 30 million people, suffer from nasal sinus disease. Although nasal obstruction and smell loss are two of the major symptoms of the…

Nasal Obstruction

Ohio State UniversityNCT05920330

Actual pay is set by the research site.

Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

Background: Myelodysplastic syndromes (MDS) occur when the cells that make blood cells are abnormal. There are limited treatment options for MDS. Researchers …

Myelodysplastic Syndromes

National Cancer Institute (NCI)NCT05350748

~$10 – $675

Actual pay is set by the research site.

Phase 1

A Pilot Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy for Patient With HER2-negative Early-stage Breast Cancer and Hyperinsulinemia

The primary objective of the study is to assess metabolic plasma markers of insulin resistance in patients with early-stage HER2-negative breast cancers receiv…

Breast CancerHyperinsulinismHER2-negative Breast Cancer

Yale UniversityNCT05989347

~$150 – $3,000

Actual pay is set by the research site.

Phase 3

An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in Mucopolysaccharidosis Type II (Hunter Syndrome) Subjects

An extension of Global Phase III open-label, multicenter designed to evaluate the Long-term safety and efficacy of study drug for the treatment of the MPS II.

Mucopolysaccharidosis II

JCR Pharmaceuticals Co., Ltd.NCT05594992

~$50 – $2,100

Actual pay is set by the research site.

Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases

This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. R…

Benign or Malignant Pancreatic Diseases

Methodist Health SystemNCT04055571

Actual pay is set by the research site.

Phase 3

A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)

The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants …

Chronic Lymphocytic LeukemiaLeukemia, LymphocyticLeukemia, B-cell+1 more

Loxo Oncology, Inc.NCT05254743

~$50 – $2,100

Actual pay is set by the research site.

Phase 2

Assessing Metabolic Changes in Multiple Sclerosis Using Hyper-polarized Carbon 13 MRI

The main purpose of this study is to assess whether hyperpolarized carbon imaging in relapsing remitting multiple sclerosis (MS) patients can be used to predic…

Multiple SclerosisRRMSRelapsing Remitting MS

~$75 – $3,000

Actual pay is set by the research site.

Ari GreenNCT07510607

InfectionInfections, BacterialInfections, Fungal+2 more

A Prospective Randomized Basket Trial Evaluating the Clinical Utility of Plasma-based Microbial Cell-free Metagenomic Sequencing for Diagnosis and Management of Suspected Infections in Adult Immunocompromised Outpatients

This clinical trial is designed to evaluate if adding the Karius Spectrum™ plasma test to usual care diagnostic tests, compared to usual care testing alone, am…

~$10 – $1,050

Actual pay is set by the research site.

Karius, Inc.NCT07110636

Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes

Suboptimal glycemic control during pregnancy contributes to adverse maternal and fetal health outcomes and previous automated insulin delivery (AID) studies ha…

Type 1 DiabetesPregnancy

Actual pay is set by the research site.

Mayo ClinicNCT07808385

Acute Hypoxemic Respiratory FailureMechanical VentilationAcute Respiratory Distress Syndrome (ARDS)

Safety and Efficacy of Low-Flow ECMO in a Multi-modal Cohort of Adults in Respiratory Failure

The current standard of care (SOC) for treatment of patients with acute respiratory distress syndrome (ARDS), inhalation injury, volume overload, and/or pulmon…

Institute for Extracorporeal Life SupportNCT06938217

~$10 – $1,050

Actual pay is set by the research site.

Phase 1

Phase I Study of Carfilzomib-based Chemotherapy Mobilization for Autologous Stem Cell Transplantation in Multiple Myeloma

This phase I study utilizes a 3+3 design with escalating cohorts of Carfilzomib at 20mg/m2, 27mg/m2, 36mg/m2, 45mg/m2, 56mg/m2, and 70mg/m2 to be administered …

Multiple Myeloma